DockCoV2
A drug database against SARS-CoV2.
The current pandemic of COVID-19 is a global health crisis. To fight the novel coronavirus, one of the best ways is to block enzymes essential for virus replications. DockCoV2 focuses on predicting FDA-approved (1,760) and Taiwan National Health Insurance (NHI) drugs (1,615) targeting five proteins from SARS-CoV-2 and provides the linkages between the molecular docking scores and the commonly-used drug databases.